PCR
PCR
  • 1 734
  • 3 198 832
TAVI for today and tomorrow - What matters the most to patients? - Webinar
Watch the replay of this webinar if you want to illustrate through case in point and the latest data, how new-generation TAVI technology would optimise the full spectrum of lifetime management to our patients, to understand what patients care the most in their TAVI journey, from first valve choice, durability to minimising patient reintervention and to discuss the latest definitions and recent clinical data evaluating valve performance.
Chapters:
00:00:00 - Introduction and session objectives
00:03:00 - Recorded case S3UR, with a smaller annulus 
00:16:45 - Contemporary view on valve performances
00:39:20 - Clinical outcome and performance of latest transcatheter bioprosthesis
00:57:18 - Closing / Key message
Переглядів: 496

Відео

Bioresorbable scaffolds - new evidence and clinical applications - Webinar
Переглядів 71814 годин тому
Watch the replay of this webinar if you want to revisit the concept and new technology of BRS, to learn about new preclinical and clinical evidence on BRS and to discuss potential clinical applications of BRS today. More PCR webinars on Stents, Scaffolds and Drug-coated Balloons: www.pcronline.com/Webinars/PCR-Webinars/Coronary-Interventions/Stents-and-Scaffolds Chapters: 00:00:00 - Introductio...
Focus on Jon DeHaan Foundation Award for Innovation in Cardiology - EuroPCR
Переглядів 4114 годин тому
Join Tom DeHaan, Rishi Puri, and Robert Schwartz as they delve into the history and purpose of the Jon DeHaan Foundation. Learn about the prestigious award's latest winner, the A-FLUX coronary sinus reducer, and the journey that led to this achievement. Discover how recognizing innovative and promising projects can benefit not only their creators but also the future patients who will gain from ...
Focus on PCR Innovators Day - EuroPCR
Переглядів 6414 годин тому
Nicole Karam and Nicolo Piazza highlighted EuroPCR 2024's PCR Innovators Day, which gathered over 400 physicians, ventures, industry partners, and investors to exchange ideas and network. Key topics included valve disease, heart failure, denervation, and the obstacles to innovation across different geographies, addressed in the innovator exchange hubs. The event concluded with a feedback sessio...
Focus on EAPCI PCR Fellows Course - EuroPCR
Переглядів 168День тому
In celebration of the tenth anniversary of the EAPCI PCR Fellows Course, Gabor Toth interviews Chiara De Biase about the initial target participants of the Course, the topics covered during this one-day event, and the decision to exclude structural topics to promote the PCR London Valves Course. Chiara also shares insights about the upcoming edition, which is already in preparation. All the mor...
Acute coronary syndrome, summary of the 2023 ESC Guidelines: a new chapter in the PCR-EAPCI Textbook
Переглядів 399День тому
Join Piera Capranzano and Robert Byrne in this #europcr 2024 video to delve into the new chapter of the PCR EAPCI Textbook on the 2023 ESC guidelines for acute coronary syndromes. This chapter highlights key points for interventional cardiologists, focusing on invasive management, antiplatelet and anti-thrombotic therapy, and revascularization in multi-vessel disease. It also addresses practica...
Coronary artery stents - A comprehensive update of the chapter in the PCR-EAPCI Textbook - EuroPCR
Переглядів 228День тому
Watch the #europcr 2024 discussion between Miklos Rohla and Stephan Windecker as they delve into the newly updated PCR-EAPCI Textbook chapter on stents, the first update in 6 years. This comprehensive resource includes pre-clinical and clinical findings, randomized trial evidence, and in-depth technical specs for all current stents. Since stents are used in a staggering 90% of PCI procedures, t...
A journey through tricuspid regurgitation phenotypes - Webinar
Переглядів 515День тому
Watch the replay of this webinar if you want to know about atrial secondary tricuspid regurgitation (TR) and management of TR in patients with cardiac implantable electronic devices (CIED), about current outcomes of T-TEER and other technologies in patients with atrial secondary TR and also surgical and endovascular management of CIED related TR. More webinars on Tricuspid/Pulmonary Valve: www....
The LANDMARK RCT: key findings and relevance in clinical practice - EuroPCR
Переглядів 2,4 тис.14 днів тому
Join Patrick Serruys, Niels Van Royen, and Andreas Baumbach in a roundtable discussing the LANDMARK RCT trial, a randomized comparison of three valves aiming to validate the Myval balloon-expandable THV. Explore the trial's methodology, clinical outcomes, and findings on this new intermediate-size device, which offers adaptability to anatomy and minimal impact on pacemakers, paravalvular leak (...
PCR Teaching Assessment Board: innovation in medical education via peer review feedback - EuroPCR
Переглядів 9014 днів тому
Victoria Jenkins, William Winjs, and Christopher Cook introduce the Teaching Assessment Board, similar to the peer review process in scientific literature. This group provides structured feedback to teachers and participants, inspired by manuscript evaluation methods to enhance educational quality. The aim is to help faculty improve their teaching abilities continuously. Data from this process,...
Align for the future with next-generation balloon expandable transcatheter heart valve technology
Переглядів 1,5 тис.14 днів тому
Tune in to this #europcr 2024 session to explore the Myval Octacor THV, a cutting-edge balloon-expandable transcatheter heart valve. Discover its advanced features, potential clinical benefits, and procedural impact. Learn about the latest updates on the Myval THV series and the LANDMARK RCT. Explore the OctaAlign technique for precise commissural alignment and witness a LIVE case featuring a p...
After ORBITA 2, what is the role of PCI in the management of angina and coronary disease patients?
Переглядів 76421 день тому
Emanuele Barbato interviews Rasha Al-Lamee, the principal investigator of the ORBITA 2 trial, about the current role of percutaneous coronary intervention (PCI). Unlike ORBITA 1, ORBITA 2 focused on the effects of angioplasty as a monotherapy, without prior anti-angina treatment. The results showed that angioplasty improved symptoms significantly, making patients more likely to be free from ang...
Key learnings from 20 years of transcatheter edge-to-edge repair - EuroPCR 2024
Переглядів 17421 день тому
Maurizio Taramasso interviews Ottavio Alfieri, a pioneering figure in valve surgery and a key contributor to the development of transcatheter edge-to-edge repair, honored with the Ethica Award at the 2024 edition of #europcr. Ottavio Alfieri discusses his journey to becoming a cardiac surgeon, the genesis of the TEER concept, and the evolution from surgical to transcatheter approaches. Watch th...
Multivessel disease in ACS - which lesions to treat and when - Webinar
Переглядів 1,6 тис.21 день тому
Watch the replay of this webinar if you want to learn about new evidence for complete revascularisation in ACS, to understand how to decide which lesions to treat and to discuss optimal timing of complete revascularisation. More webinars on other coronary interventions: www.pcronline.com/Webinars/PCR-Webinars/Coronary-Interventions/Other-Coronary-Interventions Chapters: 00:00:00 - Introduction ...
Mental health in the cathlab: is everything really ok? - EuroPCR
Переглядів 28821 день тому
Mental health in the cathlab: is everything really ok? - EuroPCR
Three tailored devices to ease the complex PCI procedures - EuroPCR 2024
Переглядів 2,4 тис.21 день тому
Three tailored devices to ease the complex PCI procedures - EuroPCR 2024
What is the optimal management of patients with CAD and left ventricle dysfunction in 2024?
Переглядів 50221 день тому
What is the optimal management of patients with CAD and left ventricle dysfunction in 2024?
Mechanical circulatory support in ACS with cardiogenic shock: where are we in 2024 - EuroPCR
Переглядів 30621 день тому
Mechanical circulatory support in ACS with cardiogenic shock: where are we in 2024 - EuroPCR
Clinical experience with DurAVR THV: a new class, biomimetic TAVI - EuroPCR
Переглядів 2,7 тис.21 день тому
Clinical experience with DurAVR THV: a new class, biomimetic TAVI - EuroPCR
Antiplatelet de-escalation after complex PCI: when and how? - EuroPCR
Переглядів 14421 день тому
Antiplatelet de-escalation after complex PCI: when and how? - EuroPCR
How will the SMART trial results impact our practice and decision making in TAVI? - EuroPCR
Переглядів 2,7 тис.21 день тому
How will the SMART trial results impact our practice and decision making in TAVI? - EuroPCR
New transcatheter solution utilizing cross-caval anchoring for untreatable TR - EuroPCR
Переглядів 1,3 тис.21 день тому
New transcatheter solution utilizing cross-caval anchoring for untreatable TR - EuroPCR
What are the challenges for TAVI in bicuspid disease? - EuroPCR
Переглядів 46221 день тому
What are the challenges for TAVI in bicuspid disease? - EuroPCR
Optimising treatment for patients with severe calcified lesions: the role of orbital atherectomy
Переглядів 1,4 тис.Місяць тому
Optimising treatment for patients with severe calcified lesions: the role of orbital atherectomy
Strengthening cardiovascular care resilience for healthier hearts: the RESIL Card project - EuroPCR
Переглядів 153Місяць тому
Strengthening cardiovascular care resilience for healthier hearts: the RESIL Card project - EuroPCR
Bioadaptor RCT 2 years: could we further improve long-term CAD outcomes vs DES? - EuroPCR
Переглядів 3,1 тис.Місяць тому
Bioadaptor RCT 2 years: could we further improve long-term CAD outcomes vs DES? - EuroPCR
QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab
Переглядів 1,5 тис.Місяць тому
QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab
From innovation to reality: the impact of Cre8 EVO technology on complex PCI - EuroPCR 2024
Переглядів 1,5 тис.Місяць тому
From innovation to reality: the impact of Cre8 EVO technology on complex PCI - EuroPCR 2024
Rapid learning curve to TTVR with the Cardiovalve device - EuroPCR 2024
Переглядів 1,8 тис.Місяць тому
Rapid learning curve to TTVR with the Cardiovalve device - EuroPCR 2024
When and how to treat the side branch in non left main bifurcations? - EuroPCR 2024
Переглядів 1 тис.Місяць тому
When and how to treat the side branch in non left main bifurcations? - EuroPCR 2024

КОМЕНТАРІ

  • @dyshonmartinez3068
    @dyshonmartinez3068 7 днів тому

    ❤Amen

  • @willbrink
    @willbrink 8 днів тому

    I'd get TAVR for sure. There's a recent 10 year study out recently.

  • @user-mn7lc6mv8p
    @user-mn7lc6mv8p 9 днів тому

    Fucking england protests east india terrorist company distroyed nepal nepali culture nepal kingdom

  • @staspastukh2005
    @staspastukh2005 10 днів тому

    Thanks!

  • @patrickmulholland8649
    @patrickmulholland8649 10 днів тому

    I have had 4 new valves fitted long process

  • @nopazjack
    @nopazjack 12 днів тому

    😊 😊L😊 😊 😊😊 😊😊 O😊 😊 😊 😊 😊

  • @ahmedzahran7016
    @ahmedzahran7016 14 днів тому

    A quick one if i may, not all antianginals had no prognostic effects, BB first-line anti anginal therapy have some prognostic effects?

  • @Safe_Place_MentalHeath
    @Safe_Place_MentalHeath 17 днів тому

    Very interesting..

  • @Jash3811
    @Jash3811 18 днів тому

    dear sir, my mother has undergone mitral value replacement with perimount magna ease 29mm in 2012 (INDIA), now the value is showing degeneration with Trivial MR and stenosis with PPG/MPG value of 21/11 mmpg. Is this TMVR a good procedure for my mother please. or can she undergo ballon valvuloplasty please as there is no MR only stenosis

  • @lucymorningstar7207
    @lucymorningstar7207 19 днів тому

    ulul

  • @arshadali-qn9fw
    @arshadali-qn9fw 21 день тому

    Please make access to PCR Book free

  • @SumanSingh-yt1cx
    @SumanSingh-yt1cx Місяць тому

    Pls show India’s presentation 😊

  • @mekdam86
    @mekdam86 Місяць тому

    in the era of AI advancing cardiac intervention procedures that allow naturally intelligent interventionalists to do less stressful yet precise PCI with more time spent on non invasive cardiac patient care and non pervasive leisure time with family, the need for RFID chip wirelessly directed, ameliorating coronary plaque in times of ACS where the speed is the key to success. This chip is actually is going to simplify the cardiac intervention books in a sense a first ACS responders including ER and primary care physicians can perform the same procedure in served and non served area and that also includes EMS!. Now, whether this radiologically going to be infra red tracked at cathlab versus other is other future pre clinical trial testing is in need to be studied. MZ MD MSc

  • @martinbergmann4141
    @martinbergmann4141 Місяць тому

    What about costs? More people need TAVI, no room for more expensive procedures.

  • @yumavaldez5203
    @yumavaldez5203 Місяць тому

    BEAUTIFUL PRESENTATION. I LEARNED A LOT FROM ALL OF YOU DOCS. GOD BLESS YOU ALL

  • @varicruse
    @varicruse Місяць тому

    Thank you for these videos My question what about if the main issue is the SB like madina 0:0:1

  • @AdventuresofNitin
    @AdventuresofNitin Місяць тому

    Amazing session! Thanks Team PCR

  • @AdventuresofNitin
    @AdventuresofNitin Місяць тому

    Congratulations Dr Fadi !

  • @WayneLeng
    @WayneLeng Місяць тому

    I'm a 74 year old and 6 months ago I had two strokes along with a pulmonary embolism and many tiny blood clots. Also had a cardiac arrest while I was in the hospital. There is evidence of older strokes from about 40 years ago. I also have a PFO which was discovered about 40-45 years ago and was told nothing had to be done. I also have migraines with aura. I am currently on Apixaban, a blood thinner.

  • @draksingh8034
    @draksingh8034 2 місяці тому

    Thank you for clearing the aspects of DCB in terms of lesion preparation, type of dissections, recoils, IVI and the type of vessels one can confidently go ahead with.

  • @RubinaNoor-lg8xt
    @RubinaNoor-lg8xt 2 місяці тому

    FFR excellent tool to guide pci That was when I used to practice in uk Now 2024 cost is so much and remember the cost has to be paid by patient I am struggling

  • @arshadali-qn9fw
    @arshadali-qn9fw 2 місяці тому

    The video quality is very poor , the slides look blurred not readable

  • @adithyavikram7
    @adithyavikram7 2 місяці тому

    Respected professor when usually you start Sglt2 inhibitors in your practice in a patient with acute mi, like immediately or 24 hours or after 72 hours or during discharge, when you want to prefer the Sglt2 inhibitor professor, thank you in anticipation.

  • @arshadali-qn9fw
    @arshadali-qn9fw 2 місяці тому

    It is meeting of Elite doctors of rich countries

  • @arshadali-qn9fw
    @arshadali-qn9fw 2 місяці тому

    It's expensive

  • @jovanniramos2420
    @jovanniramos2420 2 місяці тому

    The people who has high blood pressure need to take their medication to control High Blood Pressure

  • @dr.hakanduman6004
    @dr.hakanduman6004 2 місяці тому

  • @bricen.3303
    @bricen.3303 2 місяці тому

    Great session!

  • @sissyssis6661
    @sissyssis6661 2 місяці тому

    Ears hurt

  • @JonesBlues-lh4fy
    @JonesBlues-lh4fy 3 місяці тому

    Pretty good stuff, I just realized that Mario updated his favorite way to tackle ED and it's crazy! Although what he previously talked about was pretty decent, it was difficult to follow, I just go'ogled the latest in Mario's Thunderous Erections, it's so much simpler and potent now!

  • @draksingh8034
    @draksingh8034 3 місяці тому

    Thank you for making the concept of steps of bifurcation stenting pretty clear.

  • @ahmadsalman3471
    @ahmadsalman3471 3 місяці тому

    very informative lecture sir.

  • @shamsrehan8942
    @shamsrehan8942 3 місяці тому

    Very important lecture indeeed

  • @yaldakiani1486
    @yaldakiani1486 3 місяці тому

    Perfect and Useful,appreciate it

  • @user-cj5dy7dg3m
    @user-cj5dy7dg3m 3 місяці тому

    Very nice information, thanks.

  • @arshadali-qn9fw
    @arshadali-qn9fw 3 місяці тому

    DCB is moderen technology not available for poor population. Free whole book please

  • @arshadali-qn9fw
    @arshadali-qn9fw 3 місяці тому

    I love PCR text book , it is very very expensive plz free its access for fellows of developing world. Where one Euro exceeds 300 local currency 😢

  • @Nikesnipe
    @Nikesnipe 3 місяці тому

    Great Series !! Looking forward to Part 2

  • @fannymorales1778
    @fannymorales1778 3 місяці тому

    Gracias Actas estoy haciendo Do Los Ejercíci Os😊

  • @ap2445
    @ap2445 3 місяці тому

    Thank you for very informative technical learning from PCR.

  • @jinkirigaya2741
    @jinkirigaya2741 3 місяці тому

    Thank you for your lecture. This lecture is very very good for me to understand The current evidence of structural heart disease.

  • @TheWindows11
    @TheWindows11 4 місяці тому

    What’s the life expectancy of these valves????

  • @clashenriksen961
    @clashenriksen961 4 місяці тому

    Thank you for showing this. Kudos !!!

  • @clashenriksen961
    @clashenriksen961 4 місяці тому

    Interesting 😊👌

  • @MohanSingh-vb1tp
    @MohanSingh-vb1tp 4 місяці тому

    Hi 10

  • @fatherabdul
    @fatherabdul 4 місяці тому

    Super 🎉

  • @gabrielalejandrotrucco5101
    @gabrielalejandrotrucco5101 5 місяців тому

    Congrats for the meeting!... I had learn lots of tips!.... I'm a trouble with post-dilation sizing... For example: wich is the maximum size which I should use to post-dilate a 26 mm valve in order to avoid suture leaflets rupture?

  • @elena_torres
    @elena_torres 5 місяців тому

    Big Nieves Fan! Congrats ! ( MD Trigo is te culprit)

  • @user-sh6dv9fk6f
    @user-sh6dv9fk6f 5 місяців тому

    Traduzione in italiano ?

  • @luigibirillo6629
    @luigibirillo6629 5 місяців тому

    PCI is better than nothing